CVI Accepts, published online ahead of print on 14 October 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Krajden, M.
Right arrow Articles by Petric, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krajden, M.
Right arrow Articles by Petric, M.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00238-09
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Prevalence of Human Papillomavirus 16 and 18 Neutralizing Antibodies in Prenatal British Columbia Women

Mel Krajden*, Karuna Karunakaran, Stacy So, Joel M. Palefsky, Rachna Sharma, Darrel Cook, Amanda Yu, Ron Chow, Simon Dobson, Gina S. Ogilvie, and Martin Petric

British Columbia Centre for Disease Control, Vancouver, Canada; University of British Columbia, Vancouver, Canada; Provincial Health Services Authority Laboratories, Vancouver, Canada; University of California San Francisco, San Francisco, USA; Children's and Women's Hospital, Vancouver, Canada

* To whom correspondence should be addressed. Email: mel.krajden{at}bccdc.ca.


arrow
Abstract

HPV 16 and 18 neutralizing antibody (NAb) titers were measured in 1020 prenatal British Columbia women aged 15 to 39. HPV 16 and 18 NAb were detected in 183/1020 (17.9%) and 97/1020 (9.5%) respectively, and 39 (3.8%) had NAb to both types. Titers were similar across age strata.






Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»